Dose-finding study of the efficacy of fixed-combination artemether/lumefantrine for the treatment of multidrug-resistant plasmodium falciparum malaria in Thailand

Clinical Drug Investigation

Volumn 19, Issue 5, 2000, Pages 343-348

  Karbwang, Juntra ^a   Na Bangchang, Kesara ^b   Thanavibul, Aurathai ^c   Mull, Robert ^d   Gathmann, Isa ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b THAMMASAT UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NAUSEA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; THAILAND;

EID: 0034074344     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019050-00004     Document Type: Article

References (13)

1. 1. Harinasuta T, Suntharasamai P, Viravan C. Chloroquine resistant falciparum in Thailand. Lancet 1965; 11: 657
2. 2. Bunnag D, Harinasuta T. The current status of drug resistance in malaria. In: Howell MJ, editor. Parasitology Quo Vadis? Proceedings of the Sixth International Congress of Parasitology; 1986 Oct 23-25: Melbourne, Melbourne: Australian Academy of Science: 180-96
3. 3. Karbwang J, Na-Bangchang K, Thanavibul A, et al. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet 1992; 340: 1245-8
4. 4. Ketrangsee S, Vijayakadga S, Yamokgul P, et al. Comparative trial on the response of Plasmodium falciparum to halofantrine and mefloquine in Trad Province, Eastern Thailand. Southeast Asian J Trop Med Public Health 1992; 23: 55-8
5. 5. Karbwang J, Na-Bangchang K, Thanavibul A, et al. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Bull World Health Organ 1994; 72: 233-8
6. 6. Looareesuwan S, Wilairatana P, Vanijanonta S, et al. Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet 1992; 339: 369
7. 7. Karbwang J, Na-Bangchang K, Thanavibul A, et al. A comparative clinical trial of two different regimens of artemethermefloquine in multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 296-8
8. 8. Mull R, Gathmann I, Xiu-Qing J, et al. The comparative efficacy and tolerability of CGP 56697 and benflumetol monotherapy in the treatment of patients with Plasmodium falciparum malaria in China. Antimicrob Agents Chemother. In press
9. 9. Na-Bangchang K, Karbwang J, Thanavibul A, et al. Pharmacokinetics of the fixed combination artemether-benflumetol in uncomplicated falciparum malaria. Int J Clin Pharm Res 1999; 19: 41-6
10. 10. Ezzet F, Karbwang J, Mull R. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol 1998; 46: 553-61
11. 11. China Cooperative Research Group on qinghaosu and its Derivatives as Antimalarials. Clinical studies on the treatment of malaria with qinghaosu and its derivatives. J Tradit Chin Med 1982; 2: 45-50
12. 12. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 1992; 337: 1140-3
13. 13. Bunnag D, Viravan C, Looareesuwan S, et al. Double blind randomised clinical trials of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Public Health 1991; 22 (4): 534-8